- MedicineNet.comJul 24 09:30 PM
Title: Drug Might Fight Ebola-like Marburg Virus Category: Health News Created: 7/23/2015 12:00:00 AM Last Editorial Review: 7/24/2015 12:00:00 AM
- EurekAlert!Jul 22 02:23 PM
( US Army Medical Research Institute of Infectious Diseases ) An experimental drug that protected monkeys from the deadly Marburg virus appears to have potential for treating people who have been exposed to the virus, according to a study published in the July 23 edition of The New England Journal of Medicine. Marburg virus is closely related to Ebola virus and also causes a severe hemorrhagic ...
- Science DailyJul 02 04:18 PM
A team using electron cryomicroscopy has for the first time revealed at the atomic level the structure of a protein required for viral replication in vesicular stomatitis virus, a virus that is a model for a group of RNA viruses that includes Ebola and other threats to human health.
Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug ...Business Wire via Yahoo Canada FinanceJul 22 02:01 PM
Sarepta Therapeutics, Inc. , a developer of innovative RNA-targeted therapeutics, today announced the publication of results from a multiple ascending dose study to determine the safety of AVI-7288, a PMOplus® antisense oligonucleotide, in healthy adult volunteers, in the July 23, 2015 issue of The New England Journal of Medicine.
- News-Medical-NetJul 03 02:22 AM
Viruses need us. In order to multiply, viruses have to invade a host cell and copy their genetic information. To do so, viruses encode their own replication machinery or components that subvert the host replication machinery to their advantage.
- PharmiWebJul 22 04:11 PM
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-targeted therapeutics, today announced the publication of results from a multiple ascending dose study to determine the safety of AVI-7288, a PMO plus ® antisense oligonucleotide, in healthy adult volunteers, in the July 23, 2015 issue of The New England Journal of Medicine.
- Center for Infectious Disease Research and PolicyJul 23 04:07 PM
Middle East respiratory syndrome coronavirus (MERS-CoV) has sickened four more people in Saudi Arabia of the past 2 days, one of them fatally, according to reports from the country's Ministry of Health (MOH).
- EurekAlert!Jul 14 11:39 PM
( University of Oxford ) Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The Phase II study aims to recruit more than 600 healthy adult volunteers in the UK and France. The vaccine regimen used in the study involves two different components, Ad26.ZEBOV and MVA-BN FILO, given a few weeks apart.
- Marketwired via Yahoo! FinanceJul 01 06:00 AM
GeoVax Labs, Inc. , a biotechnology company developing innovative human vaccines using its novel platform technology, announced today it has received a Notice of Award from the U.S. National Institutes ...
- Science DailyJul 09 06:33 AM
The first large panel of antibody treatments against the chikungunya virus has been reported by investigators. The virus is not spread from person to person but spreads with a domino effect from an infected mosquito to a person and from that person to a previously uninfected mosquito, and on to the next person.
- related to marburg virus